Levocetirizin Teva

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizin Teva, is a second‑generation antihistamine presented as an oral tablet for oral use. It is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria in adults and adolescents. GNH USA supplies Levocetirizin Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizin Teva is a second‑generation antihistamine that acts on H1‑receptor mediated allergic conditions. - Allergic rhinitis: reduces nasal congestion, sneezing, and itching. - Seasonal allergic rhinitis: improves symptoms during pollen seasons. - Chronic idiopathic urticaria: alleviates hives and associated itching.

Levocetirizin Teva may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Drowsiness: mild to moderate sleepiness reported by some patients. - Headache: transient tension‑type headaches. - Dry mouth: reduced salivation causing mild discomfort. - Fatigue: a feeling of reduced energy.

Serious or Rare Side Effects: - Angioedema: swelling of the face, lips, or tongue requiring urgent care. - Anaphylaxis: severe allergic reaction with respiratory distress. - Thrombocytopenia: low platelet count that may lead to easy bruising or bleeding.

Before initiating Levocetirizin Teva, consider the following safety measures. - Assess renal function: dose may need adjustment in severe impairment. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use caution in pregnancy: discuss risks with a healthcare professional. - Monitor for sedation: avoid operating machinery if drowsiness develops. - Limit alcohol intake: may enhance central nervous system effects. - Store at below 25°C: keep in the original pack, protect from moisture.

Levocetirizin Teva can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Other H1 antihistamines: additive antihistaminic effect may increase sedation. - Ketoconazole: strong CYP3A4 inhibition can raise levocetirizine levels. - Ritonavir: potent CYP3A4 inhibitor may elevate plasma concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: may potentiate drowsiness. - CNS depressants (e.g., benzodiazepines): monitor for enhanced sedation. - QT‑prolonging drugs: observe cardiac rhythm for potential arrhythmia.